Abstract
I. Introduction
Globally, cancer of the breast is the commonest cancer followed by that of the cervix [1, 2] , but cancer of the cervix is the commonest in developing countries and the commonest genital tract malignancy. [3, 4, 5,] About half a million new cases are seen worldwide each year with over 80% of the morbidities and mortalities occurring in developing countries [6] . This is further compounded by the fact that 75% of patients in developing countries present with advanced stage disease, when only palliative treatment is possible. [7, 8] .
Cervical (pap) smear is a relatively simple cost-effective screening test done by scraping the exfoliative epithelium of the squamo -columnar junction of the cervix. This is examined cytologically to detect abnormalities that might lead to cervical cancer [9, 10, and 11] .The prevention of cervical cancer rely on routine population screening for early detection and appropriate management of precursor lesions which if untreated may advance to invasive disease or may regress spontaneously [12, 13] . Where such programs are effective there has been remarkable reduction in both morbidity and mortality from invasive cancer of the cervix [14] . No form of cancer better documents the remarkable effects of prevention, early diagnosis, and curative therapy on the mortality rate than cancer of the cervix. [2] In spite of its success and simplicity organized routine screening remains elusive in most developing countries where it is estimated that only about 5% of women have been screened for the disease with Pap smear. [12] . Most developing countries, including Nigeria, do not have organized cervical cancer screening services, despite the huge burden of cervical cancer and presence of its predisposing factors. Opportunistic screening offers the only hope of preventing cervical cancer in such settings but has severe limitations in its uptake, scope of coverage, follow-up and evaluations of its impact on reduction of clinical cervical cancer. Also, opportunistic screening is characterized by over-screening of those at low risk [15] .
A survey of gynaecologists in Nigeria on cervical cancer shows that there is a low level of screening of their patients, despite the availability of screening services in many centres [16] . The low numbers has been attributed to poor preventative health consciousness, the fear of a positive result and concerns about cost [17] .
II. Materials and Methods:
This is a retrospective study of all (cervical) Pap smears received and processed at the Department of Pathology, University of Calabar Teaching Hospital over a ten year period (January 2001 and December 2010).
Specimen adequacy was properly assessed based on presence of endocervical cells and/or metaplastic 
III. Results:
The total number of pap smears received was 848. Fourteen (1.7%) were unsatisfactory and therefore not included in the study. Eight hundred and thirty four (834) smears were analyzed. The age range of the women screened was between 17 and 73 years. The largest number of smears was between ages 40 -49years (304 = 36.4%) and 30 -39 years (252 = 30.2%) while (162 = 19.4%) were 29 years and below and (118 = 14%) were 50 years and above. Only 2.3% were 60years and above and 1.4% were less than 20 years. (Table1).
Majority of the smears 698 (83.7%) were in the category of normal or benign changes hence regarded as negative smears while 136 (16.3%) had abnormal epithelial cell changes and were regarded as positive. These were made of ASCUS 10 (1.2%), AGUS 5 (0.6%), LSIL 45 (5.4%), HSIL was found in 54 (6.5%) while invasive carcinoma was found in 22 (2.6%) patients. see table 2.
In Table 3 : the highest number of frankly cancerous smears 12 (54.6%) was found in those between 40 and 49 years, followed by 6 (27.3%) in those aged 50 to 59 years while those aged 30 to 39 had 2 (9.1%) and those 60 and above had 2 (9.1%). The lowest age of those with invasive cancer was 35 years. The HSIL smears also followed the same pattern with the age peak incidence being 40 to 49yrs with 25 (46.3%), 11 (20.4%) for age range 50 -59 yrs and 7 (12.96%) for those 30 -39 yrs and those above 60 years. Only 4 (7.4%) people below the age of 30 years had HSIL.
Low grade squamous intraepithelial lesion (LSIL) was seen in 45 cases (5.4%) with API also between 40-49 years, 7 were seen in those below 30 years while only 3 were seen above 60 years. The mean age of those with LSIL was while the mean age for those with HSIL was Atypical squamous cells of undetermined significance (ASCUS) and atypical glandular cells of undetermined significance (AGUS) were seen in 15 cases (1.8%). Table 4 
IV. Discussion:
Cervical smears are routinely taken for the purpose of screening for cervical cancer since the clinical disease may be prevented by detection and appropriate management of its precursor.
It is well established in the literature and clinical practice that, the best method of early detection of precancerous lesions of the cervix is by cytological examination of pap smears. Visual inspection of the cervix has been proposed as an alternative to cervical cytology. The unmagnified visual inspection of the cervix after the application of 3-5% acetic acid which is known as visual inspection of cervix with acetic acid (VIA) seems to be a potentially useful early detection approach. [18] There is no doubt that regular screening of sexually active women confers an overall public health benefit in reducing the morbidity and mortality from the disease. No form of cancer better documents the remarkable effects of prevention, early diagnosis, and curative therapy on the mortality rate than cancer of the cervix.
Of the eight hundred and thirty four smears analyzed 698 (83.7%) were negative smears, 136 (16.3%) smears had abnormal epithelial cell changes. This agrees with other studies done in northern, mid western and south eastern Nigeria and in Saudi Arabia [9, 19, 17, 21 and 20] while some others had very low abnormal smears [18, 22, and 23] .
The age distribution of the women in this study shows that women of all ages will accept Pap smear if they are offered the test. The majority of the women eighty four percent were within the reproductive age group, with over sixty percent in the age bracket of 30 to 49 years. Only about 1.4 percent of the women were 19 years and below with 0.8 percent of them having abnormal smears while 2.3 % were 60 years and above with 9.6% of them having abnormal smears. The increased occurrence of abnormal epithelial smears after 30 years is in agreement with those who advocate that screening should start form 30 years while the presence of abnormal smears in teenagers though small would suggest the need to screen teenagers who are sexually active. [24] The epithelial abnormalities were as follows, ASCUS 10 (1.2%), AGUS 5 (0.6%), LSIL 45 (5.4%), HGSIL was found in 54 (6.5%) while invasive carcinoma was found in 22 (2.6%) smears. These are within same limits as some other studies [9, 21,] .
Women between the ages of 35 and 60 years are at highest risk of developing cervical cancer [9] . In this study, over 95% of the women with invasive smears fall within this age bracket with the peak age incidence being between 40 and 49 years. There was no invasive cancer in those less than 30 years; the lowest age of those affected being 35 years. In a study in Sweden, the age-specific incidence of cervical carcinoma in a population that did not undergo screening showed a peak at ages 45 to 50 years and a modest decline at older age [25] just like in our study.
The HGSIL and Low grade squamous intraepithelial lesion (LSIL) smears also followed the same pattern as the invasive smears with the age peak incidence being 40 to 49yrs but while there were 7 people with LSIL below age 30, only 4 people with HSIL were below that age. There was no HSIL found below 20 years. In a study done in Saudi Arabia the age peak incidence for invasive cancer and HSIL was 50 -59 a decade later than what was found in our study [21] .
The percentage of abnormal lesions over the total number of patients in the different age brackets shows that abnormality increases with age with a very steep increase after age 40. This emphasizes the fact that there are more women affected with increasing age and hence the importance of screening.
V.

Conclusion:
Cervical screening has been shown to be an effective tool in the detection of pre-invasive stages of cervical cancer and even limited Pap smear screening reduces the incidence. This emphasizes the need for wellorganized cervical screening programs and education of the public about cervical cancer and its precursors. It is certainly going to be a mammoth task to create a mechanism to offer women cervical smears, with followup and referrals to specialist clinics for treatment if abnormal smears are detected, but if such steps are not taken, our women will continue to develop and die from what is essentially a preventable disease.
